Intraoperative ketorolac may interact with patient-specific tumour genomics to modify recurrence risk in lung adenocarcinoma: an exploratory analysis. Article uri icon

Overview

authors

  • Connolly, James
  • Scarpa, Joseph
  • Gupta, Hersh V
  • Tan, Kay See
  • Mastrogiacomo, Brooke
  • Dycoco, Joseph
  • Caso, Raul
  • Jones, Gregory D
  • Sanchez-Vega, Francisco
  • Adusumilli, Prasad S
  • Rocco, Gaetano
  • Isbell, James M
  • Bott, Matthew J
  • Irie, Takeshi
  • McCormick, Patrick J
  • Fischer, Gregory W
  • Jones, David R
  • Mincer, Joshua S

publication date

  • July 14, 2021

Research

keywords

  • Adenocarcinoma of Lung
  • Anti-Inflammatory Agents, Non-Steroidal
  • Biomarkers, Tumor
  • Ketorolac
  • Lung Neoplasms
  • Neoplasm Recurrence, Local
  • Pneumonectomy

Identity

PubMed Central ID

  • PMC8492960

Scopus Document Identifier

  • 85111482341

Digital Object Identifier (DOI)

  • 10.1016/j.bja.2021.05.032

PubMed ID

  • 34272058

Additional Document Info

volume

  • 127

issue

  • 3